Table 8.
Atorvastatin therapy and levels of blood lipids in patients with coronary artery reocclusion.
| Lipids (mg/dL) | CON n = 69 | Dist CA reocclusions n = 165 | Mid CA reocclusions n = 147 | Prox CA reocclusions n = 123 | Prox+Mid CA reocclusions n = 101 |
|---|---|---|---|---|---|
| TC | 173.3 ± 32.6 | 165.4 ± 32.4 | 180.1 ± 32.4 | 178.8 ± 34.0 | 183.4 ± 36.6 |
| TG | 124.5 ± 22.3 | 130.6 ± 20.1 | 120.5 ± 23.8 | 121.1 ± 24.9 | 131.7 ± 25.3 |
| HDL-C | 44.0 ± 7.2 | 45.3 ± 8.4 | 47.3 ± 9.0 | 40.3 ± 8.0 | 46.2 ± 9.1 |
| LDL-C | 122.6 ± 23.1 | 121.7 ± 21.3 | 129.6 ± 24.9 | 125.8 ± 25.1 | 123.9 ± 24.7 |
| VLDL-C | 24.8 ± 3.4 | 23.1 ± 3.6 | 25.3 ± 4.0 | 27.9 ± 5.3 | 28.0 ± 5.8 |
Student's t-test P > 0.05 (CON group/Dist CA reocclusion group). P > 0.05 (Dist CA reocclusion group/Mid CA reocclusion group). P > 0.05 (Mid CA reocclusion group/Prox CA reocclusion group). P > 0.05 (Prox CA reocclusion group/Prox+Mid CA reocclusion group). Group comparisons (CON/Dist CA reocclusion group/Mid CA reocclusion group/Prox CA reocclusion group/Prox+Mid CA reocclusion group) were made using ANOVA, P > 0.05.